EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Discovering a Novel AAV2-Based Capsid for RPE Transduction Via Intravitreal Injection for Leber Congenital Amaurosis Type 2 Gene Therapy

Sonali Singh, Meike Visel, Leah C Byrne, Zachary Engfer, Tyler Houston, Beth Wade, Paripoorna Sharma, Guillaume Luxardi, Krzysztof Palczewski, Ala Moshiri, John Flannery

Investigative Ophthalmology & Visual Science · 12.11.2026 · 67 (13) · 22

DOI: 10.1167/iovs.67.13.22 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Investigative Ophthalmology & Visual Science, erschienen am 12.11.2026. Verfasst von Sonali Singh und 10 weiteren Autor:innen. Beteiligte Einrichtung: Herbert Wertheim School of Optometry and Vision Science, University of California, Berkeley, California, United States. Hauptthemen laut MEDLINE: Leber Congenital Amaurosis, Retinal Pigment Epithelium, Genetic Therapy, Dependovirus. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leber Congenital AmaurosisRetinal Pigment EpitheliumGenetic TherapyDependovirusTransduction, GeneticParvovirinaeCapsidAnimalsIntravitreal InjectionsGenetic VectorsMiceGene Therapy AgentsDisease Models, AnimalMice, Inbred C57BLcis-trans-IsomerasesHumansGene Transfer TechniquesRetinoid Isomerohydrolase

Substanzen

cis-trans-IsomerasesRetinoid Isomerohydrolase

Autor:innen und Institutionen

  • Herbert Wertheim School of Optometry and Vision Science, University of California, Berkeley, California, United States.
  • Helen Wills Neuroscience Institute, University of California, Berkeley, California, United States.
  • Department of Ophthalmology, University of Pittsburgh, Pennsylvania, United States.
  • Department of Neurobiology, University of Pittsburgh, Pennsylvania, United States.
  • Department of Bioengineering, University of Pittsburgh, Pennsylvania, United States.
  • Department of Physiology and Biophysics, University of California, Irvine, California, United States.

Zitieren

APA

Singh, S., Visel, M., Byrne, L. C., Engfer, Z., Houston, T., Wade, B., Sharma, P., Luxardi, G., Palczewski, K., Moshiri, A., & Flannery, J. (2026). Discovering a Novel AAV2-Based Capsid for RPE Transduction Via Intravitreal Injection for Leber Congenital Amaurosis Type 2 Gene Therapy. Investigative Ophthalmology & Visual Science, 67(13), 22. https://doi.org/10.1167/iovs.67.13.22

Vancouver

Singh S, Visel M, Byrne LC, Engfer Z, Houston T, Wade B, et al. Discovering a Novel AAV2-Based Capsid for RPE Transduction Via Intravitreal Injection for Leber Congenital Amaurosis Type 2 Gene Therapy. Investigative Ophthalmology & Visual Science. 2026;67(13):22. doi:10.1167/iovs.67.13.22

BibTeX
@article{Singh2026,
  author = {Singh, Sonali and Visel, Meike and Byrne, Leah C and Engfer, Zachary and Houston, Tyler and Wade, Beth and Sharma, Paripoorna and Luxardi, Guillaume and Palczewski, Krzysztof and Moshiri, Ala and Flannery, John},
  title = {Discovering a Novel AAV2-Based Capsid for RPE Transduction Via Intravitreal Injection for Leber Congenital Amaurosis Type 2 Gene Therapy},
  journal = {Investigative Ophthalmology & Visual Science},
  year = {2026},
  volume = {67},
  number = {13},
  pages = {22},
  doi = {10.1167/iovs.67.13.22}
}
Kostenlos starten →